Understanding proper refrigeration requirements, in-use storage periods, and signs of medication degradation is essential for patients managing type 2 diabetes or chronic weight, ensuring optimal treatment outcomes and preventing costly medication waste
Recruitment for ME/CFS patients started just before COVID related restrictions were introduced and research was suspended: one patient and one healthy control were recruited in February 2020, others from February 2021
Support recomposition phases where fat loss and muscle preservation occur simultaneously
Trial reporting is often limited, formulations differ and the literature does not establish the safety or effectiveness of systemic GHK-Cu as part of KLOW
Low levels of glutathione are associated with many pathological conditions, such as arthritis, cardiovascular and neurodegenerative diseases, and diabetes